VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"), a multi-national epigenetics company, is the first to demonstrate the isolation and analysis of >99% pure circulating tumor-derived DNA (ctDNA).

VolitionRx (VNRX) stock jumped 70% in pre-market after achieving 99% pure tumor DNA isolation and detecting 49/49 cancers in a blind study.

The Tallahassee Democrat revisited Florida State University researchers to talk about seafood mislabeling happening in the ...

Mole discovered in Vietnam that has been isolated for centuries, with unique DNA that sheds light on its evolutionary history today ...

When closely related species mate, their offspring sometimes survive but cannot reproduce. This pattern often affects males ...

Targets $36 Billion TAM in Early Cancer Detection and MRD. Company in active discussions with global diagnostic leaders to accelerate commercialization. HENDERSON, Nev., March 18, ...

The BMW iX3 has impressed us in isolation, but it has to face up to talented rivals from Alpine, Audi, Lexus and Tesla if ...

A small dolphin washed ashore on a remote section of New Zealand’s west coast in February 2026. To a casual observer, it ...

Atlas Data Storage and imec join forces to scale DNA-based data storage LEUVEN, Belgium and SOUTH SAN FRANCISCO, Calif., March 5, 2026 /PRNewswire/ -- imec, a global leader in nanoelectronics and ...

Researchers have reported detecting all five canonical nucleobases used in DNA and RNA in samples collected from the carbonaceous asteroid Ryugu, building on analyses enabled by Japan’s Hayabusa2 ...

Luka Dončić and LeBron James power a "cosmic" Lakers victory over the Rockets. Explore how LA's elite defense and star ...

The G2 grinder is available in a refined Silver, an elegant Ivory and deep Noir. Its minimalist profile hides powerful, professional-grade engineering. Whether TUNI's G2 addresses the reality of home ...